Sentences with phrase «receiving radiotherapy»

Lin, L. C., Que, J., Lin, K. L., Leung, H. W., Lu, C. L., and Chang, C. H. Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: a double - blinded randomized study.

The difference in breast cancer - free survival between those receiving and not receiving radiotherapy (98.5 percent vs. 96.4 percent), however, was statistically significant.

It is generally agreed that around 50 per cent of cancer patients should receive radiotherapy as part of their treatment.

«Physicians in regions of high use of radiotherapy may guide patients with DCIS toward mastectomy because many of these patients are ineligible for BCS at the time of a second breast event — having already received radiotherapy — leading to mastectomy being recommended for patients who did not receive radiotherapy and are eligible for BCS.

Between 2003 and 2009, 1,326 patients were enrolled in the trial; 658 patients were randomly assigned to receive radiotherapy and 668 did not receive radiotherapy.

The investigators found that at five years, 1.3 percent of patients who received radiotherapy had IBTR, and 4.1 percent of patients who did not receive radiotherapy had IBTR.

Evidence - based recommendations report that 83 per cent of breast cancer patients should receive radiotherapy at some stage during their illness.

Not exact matches

He continued: «We can conclude from this analysis that the use of G - CSF during thoracic radiotherapy is safe and should support patients to receive the full planned course of concurrent chemo - radiotherapy and achieve the best possible benefit.

Eighty - six patients were identified who received at least two courses of thoracic radiotherapy.

For the analysis presented today, the researchers compared the toxicities and outcomes between patients who received G - CSF during concurrent chemo - radiotherapy and those who did not.

That means that roughly 36 of the 190 women who received annual mammography for 10 years and were diagnosed with breast cancer would receive unnecessary surgery, chemotherapy or radiotherapy.

Women who received partial radiotherapy reported fewer long term changes to the appearance and feel of their breast, than those who had radiotherapy to the whole breast.

Almost all prostatectomy patients received robotic surgery, and almost all external beam radiotherapy patients received intensity - modulated radiation, reflecting modern treatment technologies.

Following breast conserving surgery, some patients were treated with whole breast radiotherapy — the clinical standard — while others received partial breast radiotherapy.

«Prostate cancer patients who receive permanent radiotherapy implants twice as likely to be free of cancer after five years.»

Results from a randomised controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose - escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer - free five years later.

About half of the group (52.9 %) received other therapies such as chemotherapy, chemo - radiotherapy, or radiotherapy before surgery.

Omission of radiotherapy is a reasonable option for women age 65 or older who receive hormone therapy after breast - conserving surgery for hormone receptor - positive, axillary node - negative breast cancer, according to results of the PRIME 2 trial presented at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10 - 14.

PRIME 2 is an international, phase III, randomized, controlled trial that set out to address the question of whether whole - breast radiotherapy can be omitted in carefully defined groups of older patients receiving appropriate therapy.

Between April 1993 and March 2003, 1011 patients were randomized to four treatment arms, 252 patients received preoperative radiotherapy alone, 253 patients received preoperative radiotherapy — chemotherapy, 253 patients received preoperative radiotherapy followed by adjuvant chemotherapy, and 253 patients received preoperative radiotherapy and chemotherapy followed by adjuvant chemotherapy.

«These patients are too ill to receive any other treatment, but with stereotactic body radiotherapy we're able to deliver a safe and effective treatment in two weeks that can provide them with a substantial quality of life with minimal side effects.»

«Delaying diagnosis had a significant impact on the treatment eventually received by patients in our study,» said lead author Dr Raviteja Miriyala, senior resident, Department of Radiotherapy and Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Inclusion Criteria: • Diagnosed with Stage II / III carcinoma of the esophagus or gastroesophageal junction • Completed pre-operative chemo radiotherapy followed by surgery • Diagnosed with residual pathologic disease after being surgically rendered free of disease with negative margins following complete resection Exclusion Criteria: • Diagnosed with cervical esophageal carcinoma • Diagnosed with Stage IV resectable disease • Did not receive concurrent chemoradiotherapy prior to surgery

Lin, Y. S., Lin, L. C., and Lin, S. W. Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow - up of a double - blind randomized study with subgroup analysis.

Watch below as Bodie, a 9 - year - old yellow Labrador, receives an advanced kind of radiotherapy called Intensity - Modulated Radiation Therapy, or IMRT at Angell Animal Medical Center in Boston.

The intervention may also improve patient knowledge about radiotherapy and reduce their concerns about receiving treatment.